Cancer BiologybioRxivPreprint
GPNMB overexpression- a marker of resistance to CDK4/6 inhibitors
Yuan Gu, Ling Ruan, Yuning Hou…·Yesim Gökmen‐Polar
This study identifies GPNMB overexpression as a marker of resistance to CDK4/6 inhibitors in estrogen receptor-positive breast cancer.
DOI 10.64898/2026.03.04.709413